Sign in

CIK 0001583648

  • Non-accelerated filer
  • Smaller reporting company

PALVELLA THERAPEUTICS, INC.

Sign in to watch
Ticker
PVLA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
300784346
Phone
+1 484-253-1461
Business address
353 W. LANCASTER AVENUE, SUITE 200, WAYNE, PA, 19087
Former names
PIERIS PHARMACEUTICALS, INC., Marika Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$11,725,861
in 7 filings, $11.7M under 10b5-1 plans

Net −$11,725,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 9 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-11-11 Martini Jeffrey S Chief Scientific Officer Option exercise 10b5-1 +6,250 $9.79 $61K 6,250
2026-11-11 Martini Jeffrey S Chief Scientific Officer Sale 10b5-1 −1,650 $164.14 $271K 4,600
2026-11-11 Martini Jeffrey S Chief Scientific Officer Sale 10b5-1 −1,467 $165.78 $243K 3,133
2026-11-11 Martini Jeffrey S Chief Scientific Officer Sale 10b5-1 −1,133 $166.76 $189K 2,000
2026-11-11 Martini Jeffrey S Chief Scientific Officer Sale 10b5-1 −1,200 $167.75 $201K 800
2026-11-11 Martini Jeffrey S Chief Scientific Officer Sale 10b5-1 −600 $168.73 $101K 200
2026-11-11 Martini Jeffrey S Chief Scientific Officer Sale 10b5-1 −200 $169.78 $34K 0
2026-11-11 Martini Jeffrey S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −6,250 20,520
2026-11-10 Martini Jeffrey S Chief Scientific Officer Option exercise 10b5-1 +4,266 $7.53 $32K 4,266
2026-11-10 Martini Jeffrey S Chief Scientific Officer Option exercise 10b5-1 +1,984 $9.79 $19K 6,250
2026-11-10 Martini Jeffrey S Chief Scientific Officer Sale 10b5-1 −100 $163.34 $16K 6,150
2026-11-10 Martini Jeffrey S Chief Scientific Officer Sale 10b5-1 −1,449 $164.85 $239K 4,701
2026-11-10 Martini Jeffrey S Chief Scientific Officer Sale 10b5-1 −1,651 $165.85 $274K 3,050
2026-11-10 Martini Jeffrey S Chief Scientific Officer Sale 10b5-1 −1,500 $166.91 $250K 1,550
2026-11-10 Martini Jeffrey S Chief Scientific Officer Sale 10b5-1 −200 $167.81 $34K 1,350
2026-11-10 Martini Jeffrey S Chief Scientific Officer Sale 10b5-1 −550 $169.03 $93K 800
2026-11-10 Martini Jeffrey S Chief Scientific Officer Sale 10b5-1 −800 $172.12 $138K 0
2026-11-10 Martini Jeffrey S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −4,266 15,621
2026-11-10 Martini Jeffrey S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −1,984 26,770
2026-10-21 Goin Kathleen Chief Operating Officer Option exercise 10b5-1 +2,165 $7.14 $15K 2,165

Page 1 of 21 · 412 trades